U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT06861842) titled 'Bioequivalence Study of Lithium Carbonate 300 mg Tablets. Actilitio(R) in Healthy Subjects' on Jan. 23.
Brief Summary: A bioequivalence study of lithium carbonate will be developed in 24 healthy subjects, in fasting condition
Study Start Date: June 01, 2024
Study Type: INTERVENTIONAL
Condition:
Healthy
Healthy Donors
Intervention:
DRUG: Theralite(R)
Reference
DRUG: Actilitio(R)
Test
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Centro de Atencion e Investigacion Medica
Information provided by (Responsible Party): Humberto Reynales MD MSc PhD, Centro de Atencion e Investigacion Medica
Published by HT Digital Content...